Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice

被引:78
作者
Berul, CI
Christe, ME
Aronovitz, MJ
Seidman, CE
Seidman, JG
Mendelsohn, ME
机构
[1] TUFTS UNIV,DIV PEDIAT CARDIOL,SCH MED,NEW ENGLAND MED CTR,BOSTON,MA 02111
[2] TUFTS UNIV,DIV CARDIOL,SCH MED,NEW ENGLAND MED CTR,BOSTON,MA 02111
[3] HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02111
关键词
cardiomyopathy; hypertrophy; electrophysiology; disease models; animals; drug screening; hereditary diseases;
D O I
10.1172/JCI119197
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A new mouse cardiac electrophysiology method was used to study mice harboring an alpha-myosin heavy chain Arg403Gln missense mutation (alpha-MHC(403/+)), which results in histological and hemodynamic abnormalities characteristic of familial hypertrophic cardiomyopathy (FHC) and sudden death of uncertain etiology during exercise. Wild-type animals had completely normal cardiac electrophysiology. In contrast, FHC mice demonstrated (a) electrocardiographic abnormalities including prolonged repolarization intervals and rightward axis; (b) electrophysiological abnormalities including heterogeneous ventricular conduction properties and prolonged sinus node recovery time; and (c) inducible ventricular ectopy. These data identify distinct electrophysiologic abnormalities in FHC mice with a specific alpha-myosin mutation, and also validate a novel method to explore in vivo the relationship between specific genotypes and their electrophysiologic phenotypes.
引用
收藏
页码:570 / 576
页数:7
相关论文
共 31 条
[1]  
Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
[2]   USE OF THE RATE-CORRECTED JT INTERVAL FOR PREDICTION OF REPOLARIZATION ABNORMALITIES IN CHILDREN [J].
BERUL, CI ;
SWEETEN, TL ;
DUBIN, AM ;
SHAH, MJ ;
VETTER, VL .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (12) :1254-1257
[3]   In vivo cardiac electrophysiology studies in the mouse [J].
Berul, CI ;
Aronovitz, MJ ;
Wang, PJ ;
Mendelsohn, ME .
CIRCULATION, 1996, 94 (10) :2641-2648
[4]   COMPARISON OF QT DISPERSION IN HYPERTROPHIC CARDIOMYOPATHY BETWEEN PATIENTS WITH AND WITHOUT VENTRICULAR ARRHYTHMIAS AND SUDDEN-DEATH [J].
BUJA, G ;
MIORELLI, M ;
TURRINI, P ;
MELACINI, P ;
NAVA, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (12) :973-976
[5]   NATURAL-HISTORY OF HYPERTROPHIC CARDIOMYOPATHY - A POPULATION-BASED STUDY, 1976 THROUGH 1990 [J].
CANNAN, CR ;
REEDER, GS ;
BAILEY, KR ;
MELTON, LJ ;
GERSH, BJ .
CIRCULATION, 1995, 92 (09) :2488-2495
[6]   DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J].
EPSTEIN, ND ;
COHN, GM ;
CYRAN, F ;
FANANAPAZIR, L .
CIRCULATION, 1992, 86 (02) :345-352
[7]   HEMODYNAMIC AND ELECTROPHYSIOLOGIC EVALUATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY SURVIVING CARDIAC-ARREST [J].
FANANAPAZIR, L ;
EPSTEIN, SE .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (04) :280-287
[8]   PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS [J].
FANANAPAZIR, L ;
CHANG, AC ;
EPSTEIN, SE ;
MCAREAVEY, D .
CIRCULATION, 1992, 86 (03) :730-740
[9]   A mouse model of familial hypertrophic cardiomyopathy [J].
GeisterferLowrance, AAT ;
Christe, M ;
Conner, DA ;
Ingwall, JS ;
Schoen, FJ ;
Seidman, CE ;
Seidman, JG .
SCIENCE, 1996, 272 (5262) :731-734
[10]  
Gillette PC, 1990, PEDIAT ARRHYTHMIAS E, P216